Загрузка...
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.
Сохранить в:
| Опубликовано в: : | Mol Cell Oncol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816412/ https://ncbi.nlm.nih.gov/pubmed/31692823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2019.1650631 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|